Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Am J Physiol Endocrinol Metab ; 304(2): E197-210, 2013 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-23149621

RESUMO

This study was aimed at establishing whether specific activation of angiotensin II (ANG II) type 2 receptor (AT2R) modulates adipocyte differentiation and function. In primary cultures of subcutaneous (SC) and retroperitoneal (RET) preadipocytes, both AT2R and AT1R were expressed at the mRNA and protein level. Cells were stimulated with ANG II or the AT2R agonist C21/M24, alone or in the presence of the AT1R antagonist losartan or the AT2R antagonist PD123,319. During differentiation, C21/M24 increased PPARγ expression in both RET and SC preadipocytes while the number of small lipid droplets and lipid accumulation solely increased in SC preadipocytes. In mature adipocytes, C21/M24 decreased the mean size of large lipid droplets. Upon abolishment of AT2R expression using AT2R-targeted shRNAs, expressions of AT2R, aP2, and PPARγ remained very low, and cells were unable to differentiate. In Wistar rats fed a 6-wk high-fat/high-fructose (HFHF) diet, a significant shift toward larger adipocytes was observed in RET and SC adipose tissue depots. C21/M24 treatments for 6 wk restored normal adipocyte size distribution in both these tissue depots. Moreover, C21/M24 and losartan decreased hyperinsulinemia and improved insulin sensitivity impaired by HFHF diet. A strong correlation between adipocyte size area and glucose infusion rate during euglycemic-hyperinsulinemic clamp was observed. These results indicate that AT2R is involved in early adipocyte differentiation, while in mature adipocytes and in a model of insulin resistance AT2R activation restores normal adipocyte morphology and improves insulin sensitivity.


Assuntos
Adipócitos/patologia , Adipócitos/fisiologia , Diferenciação Celular/genética , Resistência à Insulina , Receptor Tipo 2 de Angiotensina/fisiologia , Adipócitos/efeitos dos fármacos , Adipócitos/metabolismo , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Animais , Diferenciação Celular/efeitos dos fármacos , Tamanho Celular/efeitos dos fármacos , Células Cultivadas , Dieta Hiperlipídica/efeitos adversos , Carboidratos da Dieta/efeitos adversos , Gorduras na Dieta/efeitos adversos , Frutose/efeitos adversos , Resistência à Insulina/genética , Resistência à Insulina/fisiologia , Masculino , RNA Interferente Pequeno/farmacologia , Ratos , Ratos Wistar , Receptor Tipo 2 de Angiotensina/genética , Receptor Tipo 2 de Angiotensina/metabolismo
2.
Exp Lung Res ; 37(4): 205-11, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21309733

RESUMO

Nearly 40 potassium channels have been described in respiratory epithelial cells. Of these are found several members of the 4-transmembrane domain, 2-pore K(+) channel family (K2P family), namely Twik-1 and -2, Trek-1 and -2, Task-2, -3, and -4, Thik-1, and KCNK7. The aim of this study was to verify whether the Twik-related acid-sensitive K(+) channel, subtype 1 (Task-1) (also known as KCNK3), is present in the laryngeal mucosa in the newborn lamb. Through the use of immunohistochemistry and nested polymerase chain reaction (PCR) amplification, results indicate that Task-1 protein and mRNA are present in the laryngeal mucosa, in both the ciliated, pseudostratified columnar (respiratory) epithelium and the nonkeratinized, stratified squamous epithelium. The complete ovine Task-1 protein sequence showed high homology levels with previously reported mouse, bovine, and human Task-1 sequences. This includes a complete homology for the C-terminal amino acid sequence, which is mandatory for protein trafficking to the cell membrane. These results represent the first demonstration that Task-1, a pH-sensitive channel responsible for setting membrane potential, is present in the laryngeal mucosa of a newborn mammal.


Assuntos
Mucosa Laríngea/química , Proteínas do Tecido Nervoso/análise , Canais de Potássio de Domínios Poros em Tandem/análise , Ovinos , Animais , Animais Recém-Nascidos , Concentração de Íons de Hidrogênio , Imuno-Histoquímica , Potenciais da Membrana , Proteínas do Tecido Nervoso/genética , Reação em Cadeia da Polimerase , Canais de Potássio de Domínios Poros em Tandem/genética , RNA Mensageiro/análise
3.
Mol Cell Neurosci ; 45(3): 201-12, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20600928

RESUMO

In NG108-15 cells, activation of p42/p44(mapk) is essential for induction of neurite outgrowth by angiotensin II (Ang II) type 2 receptor (AT(2)). The aim was to verify whether Fyn, a member of the Src family kinases (SFK), is involved in neurite outgrowth induced by AT(2) activation. Preincubation of cells with PP1, a general inhibitor of the SKF, decreased activation of Rap1 and p42/p44(mapk) and abolished TrkA activation by Ang II or by the AT(2) agonist, CGP42112A. NG108-15 cells were transfected with a Fyn-WT and a Fyn-DN expressing vector. Fyn-WT was sufficient to induce neurite outgrowth, although transfection with Fyn-DN abolished neurite elongation. However, the Fyn-DN form failed to affect activation of TrkA, Rap1 or p42/p44(mapk) by Ang II. Thus, although SKF activity is required to achieve AT(2)-induced activation of TrkA, Rap1 and p42/p44(mapk), Fyn is essential for AT(2) receptor-induced neurite outgrowth, but not in AT(2) signaling leading to p42/p44(mapk) activation.


Assuntos
Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , Neuritos/fisiologia , Proteínas Proto-Oncogênicas c-fyn/metabolismo , Receptor Tipo 2 de Angiotensina/metabolismo , Angiotensina II/metabolismo , Animais , Linhagem Celular , Ativação Enzimática , Humanos , Camundongos , Proteínas Proto-Oncogênicas c-fyn/genética , Ratos , Receptor Tipo 2 de Angiotensina/genética , Receptor trkA/metabolismo , Transdução de Sinais/fisiologia , Proteínas rap1 de Ligação ao GTP/metabolismo , Quinases da Família src/antagonistas & inibidores , Quinases da Família src/metabolismo
4.
Prostate ; 70(9): 921-33, 2010 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-20166102

RESUMO

BACKGROUND: Seladin-1 belongs to a subgroup of androgen-dependent genes associated with anti-proliferative, pro-differentiation, and pro-apoptotic functions and plays a protective role against oncogenic stress. The present study aims to investigate the localization and expression of Seladin-1 protein in normal and tumoral human prostatic tissues as well as to explore its role in proliferation and steroid secretion in androgen-dependent (LnCaP) and androgen-independent (DU145) cell lines and in human prostate primary cell culture. METHODS: Seladin-1 protein localization and expression were assessed on whole tissue sections by tissue array/immunohistochemistry and following immunofluorescence and Western blotting. Proliferation (Ki67 fluorescence labeling and cell counts) and steroid secretion (ELISA) were assessed in cell lines and primary epithelial cell cultures. RESULTS: In human prostatic tissue and cells, Seladin-1 was mostly localized within epithelial and rarely within stromal cells and primarily present in secretory luminal cells of normal and tumoral prostate cells. Its expression was increased in low-risk prostate cancer but reduced in advanced prostate cancers when compared to normal tissues. Seladin-1 was highly expressed in LnCaP, whereas its expression level was lower in DU145 cells. Seladin-1 inhibition by treatment with its specific inhibitor, U18666A (75 nM), increased proliferation in LnCaP and primary cell culture, as well as testosterone and dihydrotestosterone levels in both LnCaP and DU145 cell lines. CONCLUSIONS: Seladin-1 involvement in proliferation and secretion suggests that its downregulation may be a major mechanism causing prostate cancer evolution. Seladin-1 may thus potentially decrease cell growth and steroid dependency in low-grade prostate cancer.


Assuntos
Homeostase/efeitos dos fármacos , Proteínas do Tecido Nervoso/antagonistas & inibidores , Proteínas do Tecido Nervoso/metabolismo , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/antagonistas & inibidores , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/metabolismo , Próstata/metabolismo , Neoplasias da Próstata/metabolismo , Análise de Variância , Androstenos/farmacologia , Western Blotting , Contagem de Células , Linhagem Celular Tumoral , Proliferação de Células , Células Cultivadas , Inibidores Enzimáticos/farmacologia , Ensaio de Imunoadsorção Enzimática , Regulação Neoplásica da Expressão Gênica , Humanos , Imuno-Histoquímica , Masculino , Próstata/citologia , Próstata/efeitos dos fármacos , Análise Serial de Tecidos
5.
Artigo em Inglês | MEDLINE | ID: mdl-31152862

RESUMO

In Canada, 5.5 million (16% of Canadians) adults are >65 years old and projections suggest this number will be approximately 20% of Canadians by 2024. A major concern regarding old age is a decline in health, especially if this entails a loss of self-sufficiency and independence caused by a decline in cognition. The brain contains 60% of fat and is one of the most concentrated organs in long chain omega-3 fatty acids such as docosahexaenoic acid (DHA). During aging, there are physiological modifications in the metabolism of lipids that could also have consequences on brain structure and levels of DHA. This review will hence discuss the physiological modifications in the metabolism of lipids during aging with a focus on long chain omega-3 and omega-6 fatty acids and also outline the structural and functional modifications of the brain during aging including brain lipid modifications and its relation to higher levels of DHA and cognition. Therefore, in this review, we outline the importance of collecting more data on the biology of aging since it might highly improve our understanding about what are «normal¼ modifications occurring during aging and what can become pathological.


Assuntos
Envelhecimento/metabolismo , Envelhecimento/fisiologia , Encéfalo/metabolismo , Encéfalo/fisiologia , Ácidos Graxos Ômega-3/metabolismo , Cognição/fisiologia , Ácidos Graxos Ômega-6/metabolismo , Humanos
6.
Endocrinology ; 149(6): 2923-33, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18326001

RESUMO

Angiotensin II (Ang II) has been reported to induce migration in neuronal cell types. Using time-lapse microscopy, we show here that Ang II induces acceleration in NG108-15 cell migration. This effect was antagonized by PD123319, a selective AT2 receptor antagonist, but not by DUP753, a selective AT1 receptor antagonist, and was mimicked by the specific AT2 receptor agonist CGP42112. This Ang II-induced acceleration was not sensitive to the inhibition of previously described signaling pathways of the AT2 receptor, guanylyl cyclase/cyclic GMP or p42/p44 mapk cascades, but was abolished by pertussis toxin treatment and involved PP2A activation. Immunofluorescence studies indicate that Ang II or CGP42112 decreased the amount of filamentous actin at the leading edge of the cells. This decrease was accompanied by a concomitant increase in globular actin levels. Regulation of actin turnover in actin-based motile systems is known to be mainly under the control of the actin depolymerizing factor and cofilin. Basal migration speed decreased by 77.2% in cofilin-1 small interfering RNA-transfected NG108-15 cells, along with suppression of the effect of Ang II. In addition, the Ang II-induced increase in cell velocity was abrogated in serum-free medium as well as by genistein or okadaic acid treatment in a serum-containing medium. Such results indicate that the AT2 receptor increases the migration speed of NG108-15 cells and involves a tyrosine kinase activity, followed by phosphatase activation, which may be of the PP2A type. Therefore, the present study identifies actin depolymerization and cofilin as new targets of AT2 receptor action, in the context of cellular migration.


Assuntos
Actinas/metabolismo , Movimento Celular/fisiologia , Receptor Tipo 2 de Angiotensina/fisiologia , Angiotensina II/farmacologia , Animais , Linhagem Celular Tumoral , Cofilina 1/genética , Cofilina 1/farmacologia , Imidazóis/farmacologia , Cinética , Camundongos , Neuroblastoma , Monoéster Fosfórico Hidrolases/metabolismo , Piridinas/farmacologia , RNA Interferente Pequeno/genética , Receptor Tipo 2 de Angiotensina/efeitos dos fármacos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transfecção
7.
J Steroid Biochem Mol Biol ; 109(3-5): 224-9, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18468884

RESUMO

The adrenal cortex undergoes constant dynamic structural changes, a key element in ensuring integrative functionality of the gland. Studies have shown that the cellular environment can modulate cell functions such as proliferation and steroid secretion. For example, 3-day treatment with angiotensin II promotes protein synthesis with a concomitant decrease in proliferation of glomerulosa cells, when cultured on fibronectin, but not on collagen IV or laminin. These effects involve close interaction between cytoskeleton-associated proteins and activation of p42/p44mapk and p38 MAPK pathways. On the other hand, adrenocorticotropin hormone (ACTH), which is clearly the most potent stimulus of fasciculata cells, induces specific modulation of targeted proteins, when cells are cultured on collagen IV, but not on fibronectin or laminin. In particular, ACTH treatment leads to increased expression of Seladin-1 and induces the relocalization of Seladin-1 from the cytoplasm to the nucleus, both in vivo and in culture conditions, in adult rats and in human fetal adrenal glands. As a whole, these results indicate that Seladin-1, together with collagen IV, is able to modulate ACTH responsiveness. Hence, Seladin-1 may participate in the regulation of steroidogenesis when localized in the cytoplasm, while conversely protecting cells against oxidative stress generated by intense ACTH stimulation when massively localized in the nucleus.


Assuntos
Doenças Metabólicas/metabolismo , Transdução de Sinais , Glândulas Suprarrenais/citologia , Glândulas Suprarrenais/efeitos dos fármacos , Glândulas Suprarrenais/metabolismo , Hormônio Adrenocorticotrópico/farmacologia , Angiotensina II/farmacologia , Animais , Proliferação de Células , Células Cultivadas , Colágeno Tipo IV/metabolismo , Feminino , Fibronectinas/farmacologia , Humanos , Proteínas do Tecido Nervoso/metabolismo , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/metabolismo , Biossíntese de Proteínas/efeitos dos fármacos , Ratos , Ratos Long-Evans
8.
J Endocrinol ; 192(1): 53-66, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17210742

RESUMO

Seladin-1 (KIAA0018) gene is the seventh most highlyexpressed gene in the adult adrenal gland, along with genes coding for steroidogenic enzymes. The aim of the present study was to investigate the localization of the Seladin-1 protein in control and ACTH-treated rat adrenal glands and to verify whether Seladin-1 is involved in secretion. Immunofluorescence studies revealed that Seladin-1 was localized principally in the zona fasciculata, cytoplasm, and nucleus. Expression of Seladin-1 was increased by ACTH treatment, in vivo and in culture conditions. Subcellular fractionation offasciculata cells showed that Seladin-1 was mainly present in the nucleus, membrane, and cytoskeleton fractions and, to a lesser extent, in the cytosol. ACTH treatment decreased Seladin-1 expression in the cytosol, with a concomitant increase in the nuclear fraction. In the glomerulosa and fasciculata cells in culture, ACTH induced a relocalization of Seladin-1 into specific nuclear regions. This ACTH-induced relocalization was abrogated by the pre-treatment of cells with 75 nM U18666A (an inhibitor of Seladin-1). In addition, fasciculata cells exhibited an increase in the basal level of steroid secretion when cultured in the presence of U18666A (25 and 75 nM), although ACTH-induced secretion was decreased. In summary, the present study demonstrates that the protein expression of Seladin-1 is more abundant in fasciculata cells than in glomerulosa cells and that the ACTH treatment increases both expression and nuclear localization of the protein. Results also suggest that depending on its cellular localization, the Delta24-reductase activity of Seladin-1 may play a major role in steroid secretion in the adrenal gland.


Assuntos
Glândulas Suprarrenais/química , Proteínas do Tecido Nervoso/análise , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/análise , Glândulas Suprarrenais/efeitos dos fármacos , Glândulas Suprarrenais/metabolismo , Hormônio Adrenocorticotrópico/farmacologia , Aldosterona/análise , Aldosterona/metabolismo , Androstenos/farmacologia , Animais , Western Blotting/métodos , Núcleo Celular/química , Proliferação de Células , Células Cultivadas , Corticosterona/análise , Corticosterona/metabolismo , Citoplasma/química , Primers do DNA , Inibidores Enzimáticos/farmacologia , Feminino , Imunofluorescência , Expressão Gênica/efeitos dos fármacos , Soros Imunes/isolamento & purificação , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/imunologia , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/genética , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/imunologia , Distribuição Aleatória , Ratos , Ratos Endogâmicos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Zona Fasciculada/química
9.
Endocrinology ; 145(4): 1810-22, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-14691016

RESUMO

Previous studies have shown that leptin can regulate the adrenocortical axis. Neonatal rodents exhibit a period of adrenal hyporesponsiveness to stress in the first 2 wk of life, and we determined the role of leptin as a mediator of this process. We examined the direct effects of leptin on neonatal adrenal steroidogenic responses to ACTH under basal conditions and after 24-h maternal separation. In isolated adrenocortical cells from as early as postnatal d 5 (PND5) and throughout the neonatal period, acute (2.5 h) incubation with leptin significantly inhibited ACTH-stimulated corticosterone and aldosterone secretion without affecting cAMP production. In PND10 pups, 24-h maternal separation and the resulting rapid decline in plasma leptin levels increased basal corticosterone and aldosterone secretion in vivo and in isolated cells, but did not modify the ability of leptin to inhibit stimulated steroid production in vitro. Maternal separation in PND10 pups increased adrenal expression of steroidogenic acute regulatory protein (StAR) and peripheral-type benzodiazepine receptor (PBR) proteins as well as all steroidogenic enzymes measured (3beta-hydroxysteroid dehydrogenase, P450C11B1, and P450C11B2). Leptin (1 mg/kg body weight, i.p.) replacement during maternal separation did not affect basal corticosterone output, but reduced corticosterone secretion and StAR and PBR protein expression induced by exogenous ACTH challenge (20 or 80 microg/kg body weight, i.p.). These results indicate that leptin inhibits ACTH-stimulated secretion of corticosterone and aldosterone, at least through a rapid reduction in the expression of StAR and PBR protein in the neonatal adrenal gland. As leptin concentrations in pups are controlled to a large extent by the maternal diet, these results emphasize the key role of leptin to mediate the maternal influence on the adrenocortical axis of the infant.


Assuntos
Hormônio Adrenocorticotrópico/fisiologia , Leptina/fisiologia , Esteroides/biossíntese , 3-Hidroxiesteroide Desidrogenases/metabolismo , Glândulas Suprarrenais/efeitos dos fármacos , Glândulas Suprarrenais/metabolismo , Glândulas Suprarrenais/fisiologia , Hormônio Adrenocorticotrópico/farmacologia , Envelhecimento/metabolismo , Animais , Animais Recém-Nascidos/metabolismo , Animais Recém-Nascidos/fisiologia , AMP Cíclico/metabolismo , Citocromo P-450 CYP11B2/metabolismo , Feminino , Membranas Intracelulares/metabolismo , Leptina/sangue , Leptina/farmacologia , Privação Materna , Ratos , Receptores de Superfície Celular/metabolismo , Receptores para Leptina , Transdução de Sinais/fisiologia , Esteroide 11-beta-Hidroxilase/metabolismo
10.
Endocrinology ; 150(9): 4180-90, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19520779

RESUMO

DHCR24 (24-dehydrocholesterol reductase), or seladin-1, is one of the most expressed genes in the adrenal gland. Because the rat and human adult adrenal cortex differ in their respective functional properties, the aim of the present study was to verify whether seladin-1 may be differentially involved in basal and ACTH-stimulated steroidogenesis and oxidative stress management. Seladin-1 expression was predominantly observed in both human and rat zona fasciculata, with a predominant cytoplasmic localization in human cells and a nucleo-cytoplasmic distribution in rat cells. In human fasciculata cells, localization of the protein was primarily associated with the endoplasmic reticulum. Although its expression was increased by ACTH, its intracellular localization was not altered by ACTH treatment (10 nm) or by the seladin-1 inhibitor U18666A (75 nm). Preincubation with U18666A did not modify the ACTH-induced increase in cortisol secretion but abolished the ACTH-induced increase in dehydroepiandrosterone secretion. In rat fasciculata cells, ACTH induced a massive redistribution of seladin-1 from the cytoplasm (cis-Golgi apparatus) to the nucleus, which was inhibited by preincubation with U18666A. Preincubation with U18666A also decreased ACTH-induced seladin-1 and 11beta-hydroxylase protein expression as well as corticosterone production, increased ACTH-induced ROS production but decreased ACTH-induced expression of the detoxifying protein aldo-ketoreductase 1b7. Thus, protection against acutely elevated ACTH-induced oxidative stress in rat fasciculata cells is correlated with nuclear relocalization of seladin-1 and its effects on cellular detoxifying machinery. Altogether, these results indicate that seladin-1 expression and intracellular localization are correlated with both the intensity and nature of ACTH-induced steroidogenesis and resultant oxidative stress.


Assuntos
Córtex Suprarrenal/metabolismo , Hormônio Adrenocorticotrópico/fisiologia , Proteínas do Tecido Nervoso/fisiologia , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/fisiologia , Adolescente , Hormônio Adrenocorticotrópico/farmacologia , Adulto , Idoso de 80 Anos ou mais , Aldeído Redutase/metabolismo , Androstenos/farmacologia , Animais , Núcleo Celular/enzimologia , Corticosterona/metabolismo , Desidroepiandrosterona/metabolismo , Retículo Endoplasmático/enzimologia , Feminino , Complexo de Golgi/enzimologia , Humanos , Masculino , Pessoa de Meia-Idade , Proteínas do Tecido Nervoso/antagonistas & inibidores , Estresse Oxidativo/efeitos dos fármacos , Oxirredutases atuantes sobre Doadores de Grupo CH-CH/antagonistas & inibidores , Ratos , Distribuição Tecidual
11.
Am J Physiol Endocrinol Metab ; 293(6): E1465-78, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17911338

RESUMO

The aim of this review is to explore the dysregulation of adrenocortical secretions as a major contributor in the development of obesity and insulin resistance. Disturbance of adipose tissue physiology is one of the primary events in the development of pathologies associated with the metabolic syndrome, such as obesity and type 2 diabetes. Several studies indicate that alterations in metabolism of glucocorticoids (GC) and androgens, as well as aldosterone in excess, are involved in the emergence of metabolic syndrome. Cross talk among adipose tissue, the hypothalamo-pituitary complex, and adrenal gland activity plays a major role in the control of food intake, glucose metabolism, lipid storage, and energy balance. Perturbation of this cross talk induces alterations in the regulatory mechanisms of adrenocortical steroid synthesis, secretion, degradation, and/or recycling, at the level of the zonae glomerulosa (aldosterone), fasciculata (GC and GC metabolites), and reticularis (androgens and androgen precursors DHEA and DHEAS). As a whole, these adrenocortical perturbations contribute to the development of metabolic syndrome at both the paracrine and systemic level by favoring the physiological dysregulation of organs responsive to aldosterone, GC, and/or androgens, including adipose tissue.


Assuntos
Córtex Suprarrenal/fisiopatologia , Resistência à Insulina/fisiologia , Obesidade/fisiopatologia , Tecido Adiposo/metabolismo , Aldosterona/fisiologia , Androgênios/fisiologia , Animais , Humanos , Modelos Biológicos , Obesidade/metabolismo , Sistema Renina-Angiotensina/fisiologia
12.
Endocr Res ; 30(4): 837-44, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15666834

RESUMO

Leptin is most studied for its primary role in the CNS control of energy balance and food intake in humans and rodents, yet it has functions on multiple target sites including the adrenal gland. In adult rodents, leptin has been shown to inhibit adrenal steroidogenesis and we have recently demonstrated that some of the mechanisms responsible for leptin-induced inhibition of adrenal glucocorticoid production, namely a reduction of StAR protein expression are already present in the neonatal adrenal gland. The effect of leptin on the neonatal adrenal gland integrates well with the previously demonstrated effect of this protein to inhibit stress responses, enhance glucocorticoid receptor expression in the CNS and sensitivity to glucocorticoid inhibitory feedback in neonates. The leptin receptor isoform and intracellular mechanisms involved in regulation of the adrenocortical activity at multiple levels might differ between target tissues (CNS vs periphery) and age (neonates vs adult). Neonatal leptin represents an important regulator of adrenocortical function during a critical period of brain development, which is exquisitely sensitive to circulating glucocortcoid concentrations. Since circulating leptin levels in neonates vary according to maternal diet, this protein can be viewed as a critical link between environmental and maternal factors and the developing physiology of the infant.


Assuntos
Glândulas Suprarrenais/efeitos dos fármacos , Animais Recém-Nascidos , Encéfalo/metabolismo , Retroalimentação Fisiológica/efeitos dos fármacos , Glucocorticoides/metabolismo , Recém-Nascido , Leptina/farmacologia , Animais , Humanos
13.
Biol Reprod ; 69(5): 1697-706, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12890725

RESUMO

The implantation period is a critical time for embryonic survival in pigs. During this period, numerous growth factors are secreted by the conceptuses and the uterine endometrium in order to establish pregnancy and to provide a proper environment for embryonic development. It is well known that the Chinese Meishan sows have a larger litter size when compared with occidental sows mainly because of a superior embryonic survival rate. As a further step toward understanding the mechanisms involved in embryonic survival, we used a suppression subtractive hybridization technique to identify genes that were differentially expressed in Meishan-Landrace conceptuses and endometrial tissue at Day 15 of gestation when compared with conventional Landrace sows. Of the 1000 subtractive clones isolated from each library, 137 endometrial and 166 conceptus-enriched cDNAs were single-pass sequenced and examined by BLAST analysis for identification. Sixty-two percent of the clones found in the endometrial library and 78% of the clones found in the conceptus library showed homology with known genes. Among these genes, the 20 most relevant to embryonic survival based on the available literature were validated through real-time reverse-transcriptase polymerase chain reaction (RT-PCR) analysis. Our results show that suppression subtractive hybridization is a powerful method applicable in identifying putative candidate genes that might be used for selection of high litter-size breeds.


Assuntos
Embrião de Mamíferos/metabolismo , Endométrio/metabolismo , Regulação da Expressão Gênica no Desenvolvimento/fisiologia , Prenhez/metabolismo , Animais , Clonagem Molecular , Primers do DNA , DNA Complementar/biossíntese , DNA Complementar/genética , Implantação do Embrião/fisiologia , Ciclo Estral/fisiologia , Feminino , Biblioteca Gênica , Hibridização In Situ , Gravidez , RNA Mensageiro/biossíntese , RNA Mensageiro/isolamento & purificação , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Especificidade da Espécie , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA